Phase II Study Temozolomide for Retinoblastoma Metastatic to the Central Nervous System for Patients From Guatemala
Clinical trial NCT01857752 · TERMINATED
Trial details
- NCT number
- NCT01857752
- Sponsor
- Stanford University
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-03-01
- Primary completion
- 2015-06-01
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.